×

Drug pricing dilemma

8:04 AM ET Thu, 25 Aug 2016

Scott Gottlieb, AEI resident fellow, and Sam Waksal, Kadmon Corporation, discuss the controversy surround the price hikes of Mylan's EpiPen and the problems that arise when companies obtain monopolies on certain drugs.